1. Marshall J 2002 Control of Pituitary Hormone Secretion – Role of Pulsatility. In: Besser G, Thorner M eds. Comprehensive Clinical Endocrinology. Edinburgh, UK: Mosby; 19-34
2. Doniach I 1985 Histopathology of the pituitary. Clin Endocrinol Metab 14:765-789
3. McKusick V, Phillips JI, Hamosh A, Tiller G, O'Neill M 2007 Pro-opiomelanocortin. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD, USA: Johns Hopkins University
4. Drouin J, Chamberland M, Charron J, Jeannotte L, Nemer M 1985 Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett 193:54-58
5. Therrien M, Drouin J 1991 Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Mol Cell Biol 11:3492-3503
6. Therrien M, Drouin J 1993 Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 13:2342-2353
7. Poulin G, Turgeon B, Drouin J 1997 NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 17:6673-6682
8. Lamonerie T, Tremblay JJ, Lanctot C, Therrien M, Gauthier Y, Drouin J 1996 Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 10:1284-1295
9. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J 2001 A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849-859
10. Ezzat S, Mader R, Yu S, Ning T, Poussier P, Asa SL 2005 Ikaros integrates endocrine and immune system development. J Clin Invest 115:1021-1029
11. Aguilera G, Harwood JP, Wilson JX, Morell J, Brown JH, Catt KJ 1983 Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. J Biol Chem 258:8039-8045
12. Jin WD, Boutillier AL, Glucksman MJ, Salton SR, Loeffler JP, Roberts JL 1994 Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein. Mol Endocrinol 8:1377-1388
13. Autelitano DJ, Cohen DR 1996 CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol Cell Endocrinol 119:25-35
14. Boutillier AL, Monnier D, Koch B, Loeffler JP 1994 Pituitary adenyl cyclase-activating peptide: a hypophysiotropic factor that stimulates proopiomelanocortin gene transcription, and proopiomelanocortin-derived peptide secretion in corticotropic cells. Neuroendocrinology 60:493-502
15. Suda T, Tozawa F, Yamada M, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Demura H, Shizume K 1988 Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro. J Clin Invest 82:110-114
16. Drouin J, Charron J, Gagner JP, Jeannotte L, Nemer M, Plante RK, Wrange O 1987 Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J Cell Biochem 35:293-304
17. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M, Schmidt TJ 1993 Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. Embo J 12:145-156
18. Autelitano DJ, Lundblad JR, Blum M, Roberts JL 1989 Hormonal regulation of POMC gene expression. Annu Rev Physiol 51:715-726
19. Pozzoli G, Bilezikjian LM, Perrin MH, Blount AL, Vale WW 1996 Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137:65-71
20. Ray DW, Ren SG, Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 97:1852-1859
21. Ray DW, Ren SG, Melmed S 1998 Leukemia inhibitory factor regulates proopiomelanocortin transcription. Ann N Y Acad Sci 840:162-173
22. Bousquet C, Zatelli MC, Melmed S 2000 Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest 106:1417-1425
23. Benjannet S, Rondeau N, Day R, Chretien M, Seidah NG 1991 PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci U S A 88:3564-3568
24. Chretien M, Seidah NG 1981 Chemistry and biosynthesis of pro-opiomelanocortin. ACTH, MSH's, endorphins and their related peptides. Mol Cell Biochem 34:101-127
25. Seidah NG, Chretien M 1981 Complete amino acid sequence of a human pituitary glycopeptide: an important maturation product of pro-opiomelanocortin. Proc Natl Acad Sci U S A 78:4236-4240
26. Seidah NG, Rochemont J, Hamelin J, Benjannet S, Chretien M 1981 The missing fragment of the pro-sequence of human pro-opiomelanocortin: sequence and evidence for C-terminal amidation. Biochem Biophys Res Commun 102:710-716
27. Eipper BA, Mains RE 1980 Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr Rev 1:1-27
28. Bradbury AF, Smyth DG, Snell CR 1976 Prohormones of beta-melanotropin (beta-melanocyte-stimulating hormone, beta-MSH) and corticotropin (adrenocorticotropic hormone, ACTH): structure and activation. Ciba Found Symp 41:61-75
29. Barnea A, Cho G 1983 Acetylation of adrenocorticotropin and beta-endorphin by hypothalamic and pituitary acetyltransferases. Neuroendocrinology 37:434-439
30. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397
31. Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S 1983 Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. Embo J 2:775-779
32. Sawchenko PE, Swanson LW 1985 Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44:221-227
33. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A 90:8967-8971
34. DeBold CR, DeCherney GS, Jackson RV, Sheldon WR, Alexander AN, Island DP, Rivier J, Vale W, Orth DN 1983 Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol. J Clin Endocrinol Metab 57:294-298
35. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269:27088-27092
36. Raymond V, Leung PC, Veilleux R, Labrie F 1985 Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. FEBS Lett 182:196-200
37. Abou-Samra AB, Catt KJ, Aguilera G 1986 Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. Endocrinology 118:212-217
38. Plotsky PM 1988 Hypophysiotropic regulation of stress-induced ACTH secretion. Adv Exp Med Biol 245:65-81
39. Bilezikjian LM, Woodgett JR, Hunter T, Vale WW 1987 Phorbol ester-induced down-regulation of protein kinase C abolishes vasopressin-mediated responses in rat anterior pituitary cells. Mol Endocrinol 1:555-560
40. Levin N, Blum M, Roberts JL 1989 Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary. Endocrinology 125:2957-2966
41. Brownstein MJ, Russell JT, Gainer H 1980 Synthesis, transport, and release of posterior pituitary hormones. Science 207:373-378
42. Legros JJ, Chiodera P, Demey-Ponsart E 1982 Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects. J Clin Endocrinol Metab 55:1035-1039
43. Legros JJ, Chiodera P, Geenen V, von Frenckell R 1987 Confirmation of the inhibitory influence of exogenous oxytocin on cortisol and ACTH in man: evidence of reproducibility. Acta Endocrinol (Copenh) 114:345-349
44. Lewis DA, Sherman BM 1985 Oxytocin does not influence adrenocorticotropin secretion in man. J Clin Endocrinol Metab 60:53-56
45. Antoni FA, Holmes MC, Kiss JZ 1985 Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats. Endocrinology 117:1293-1299
46. Gibbs DM, Vale W, Rivier J, Yen SS 1984 Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin. Life Sci 34:2245-2249
47. Alexander LD, Evans K, Sander LD 1995 A possible involvement of VIP in feeding-induced secretion of ACTH and corticosterone in the rat. Physiol Behav 58:409-413
48. Alexander LD, Sander LD 1995 Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Neuropeptides 28:167-173
49. Jirikowski GF, Back H, Forssmann WG, Stumpf WE 1986 Coexistence of atrial natriuretic factor (ANF) and oxytocin in neurons of the rat hypothalamus. Neuropeptides 8:243-249
50. King MS, Baertschi AJ 1989 Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells. Endocrinology 124:286-292
51. Kellner M, Wiedemann K, Holsboer F 1992 Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 50:1835-1842
52. Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM, Grossman A 1991 Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. J Endocrinol 131:163-167
53. Taylor T, Dluhy RG, Williams GH 1983 beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. J Clin Endocrinol Metab 57:592-596
54. Tsagarakis S, Navarra P, Rees LH, Besser M, Grossman A, Navara P 1989 Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro [published erratum appears in Endocrinology 1989 Dec;125(6):3095]. Endocrinology 124:2330-2335
55. Jackson RV, Grice JE, Hockings GI, Torpy DJ 1995 Naloxone-induced ACTH release: mechanism of action in humans. Clin Endocrinol (Oxf) 43:423-424
56. Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grubler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B, Stalla GK 2001 Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab 86:2687-2696
57. Wade MR, Degroot A, Nomikos GG 2006 Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents. Eur J Pharmacol 551:162-167
58. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U 2006 Requirement of Cannabinoid Receptor Type 1 for the Basal Modulation of Hypothalamic-Pituitary-Adrenal Axis Function. Endocrinology
59. Benowitz NL, Jones RT, Lerner CB 1976 Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man. J Clin Endocrinol Metab 42:938-941
60. al-Damluji S 1993 Adrenergic control of the secretion of anterior pituitary hormones. Baillieres Clin Endocrinol Metab 7:355-392
61. Korbonits M, Kaltsas G, Perry LA, Grossman AB, Monson JP, Besser GM, Trainer PJ 1999 Hexarelin as a test of pituitary reserve in patients with pituitary disease. Clin Endocrinol (Oxf) 51:369-375
62. Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ 1999 The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489-2495
63. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
64. Perras B, Schultes B, Schwaiger R, Metz C, Wesseler W, Born J, Fehm HL 2002 Growth hormone-releasing hormone facilitates hypoglycemia-induced release of cortisol. Regul Pept 110:85-91
65. Gaillard RC, Favrod-Coune CA, Capponi AM, Muller AF 1985 Corticotropin-releasing activity of the renin-angiotensin system peptides in rat and in man. Neuroendocrinology 41:511-517
66. Rivier C, Vale W 1983 Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor. Regul Pept 7:253-258
67. Murakami K, Ganong WF 1987 Site at which angiotensin II acts to stimulate ACTH secretion in vivo. Neuroendocrinology 46:231-235
68. Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M, Demura H 1991 Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology 128:2248-2252
69. Engler D, Redei E, Kola I 1999 The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr Rev 20:460-500
70. Stafford PJ, Kopelman PG, Davidson K, McLoughlin L, White A, Rees LH, Besser GM, Coy DH, Grossman A 1989 The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. Clin Endocrinol (Oxf) 30:661-666
71. Fehm HL, Voigt KH, Lang R, Beinert KE, Raptis S, Pfeiffer EF 1976 Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr 54:173-175
72. Redei E, Hilderbrand H, Aird F 1995 Corticotropin release inhibiting factor is encoded within prepro-TRH. Endocrinology 136:1813-1816
73. Redei E, Hilderbrand H, Aird F 1995 Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199). Endocrinology 136:3557-3563
74. Nicholson WE, Orth DN 1996 Preprothyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release. Endocrinology 137:2171-2174
75. Besedovsky HO, del Rey A 1996 Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17:64-102
76. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G 1990 Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 71:452-463
77. Krishnan KR, Ritchie JC, Saunders W, Wilson W, Nemeroff CB, Carroll BJ 1990 Nocturnal and early morning secretion of ACTH and cortisol in humans. Biol Psychiatry 28:47-57
78. Desir D, Van Cauter E, Beyloos M, Bosson D, Golstein J, Copinschi G 1986 Prolonged pulsatile administration of ovine corticotropin-releasing hormone in normal man. J Clin Endocrinol Metab 63:1292-1299
79. Gambacciani M, Liu JH, Swartz WH, Tueros VS, Rasmussen DD, Yen SS 1987 Intrinsic pulsatility of ACTH release from the human pituitary in vitro. Clin Endocrinol (Oxf) 26:557-563
80. Dunlap JC 1999 Molecular bases for circadian clocks. Cell 96:271-290
81. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS 1990 Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 5:127-134
82. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS 1992 Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock. Science 255:1581-1584
83. Crosio C, Cermakian N, Allis CD, Sassone-Corsi P 2000 Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci 3:1241-1247
84. Watabe T, Tanaka K, Kumagae M, Itoh S, Hasegawa M, Horiuchi T, Miyabe S, Ohno H, Shimizu N 1987 Diurnal rhythm of plasma immunoreactive corticotropin-releasing factor in normal subjects. Life Sci 40:1651-1655
85. Cunnah D, Jessop DS, Besser GM, Rees LH 1987 Measurement of circulating corticotrophin-releasing factor in man. J Endocrinol 113:123-131
86. Ur E, Capstick C, McLoughlin L, Checkley S, Besser GM, Grossman A 1995 Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man. Neuroendocrinology 61:191-197
87. Yamase K, Takahashi S, Nomura K, Haruta K, Kawashima S 1991 Circadian changes in arginine vasopressin level in the suprachiasmatic nuclei in the rat. Neurosci Lett 130:255-258
88. Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM 1999 A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 96:57-68
89. Plotsky PM, Bruhn TO, Vale W 1985 Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 117:323-329
90. Plotsky PM, Bruhn TO, Vale W 1985 Evidence for multifactor regulation of the adrenocorticotropin secretory response to hemodynamic stimuli. Endocrinology 116:633-639
91. Berkenbosch F, De Goeij DC, Tilders FJ 1989 Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology 125:28-34
92. Meeran K, Hattersley A, Mould G, Bloom SR 1993 Venepuncture causes rapid rise in plasma ACTH. Br J Clin Pract 47:246-247
93. Ma XM, Levy A, Lightman SL 1997 Rapid changes in heteronuclear RNA for corticotrophin-releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol 152:81-89
94. Ma XM, Aguilera G 1999 Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Brain Res Mol Brain Res 68:129-140
95. Aguilera G, Rabadan-Diehl C 2000 Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96:23-29
96. Kim CK, Rivier CL 2000 Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology 141:2244-2253
97. Bernstein HG, Keilhoff G, Seidel B, Stanarius A, Huang PL, Fishman MC, Reiser M, Bogerts B, Wolf G 1998 Expression of hypothalamic peptides in mice lacking neuronal nitric oxide synthase: reduced beta-END immunoreactivity in the arcuate nucleus. Neuroendocrinology 68:403-411
98. Yamada K, Emson P, Hokfelt T 1996 Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. Journal of chemical neuroanatomy 10:295-316
99. Keilhoff G, Seidel B, Reiser M, Stanarius A, Huang PL, Bogerts B, Wolf G, Bernstein HG 2001 Lack of neuronal NOS has consequences for the expression of POMC and POMC-derived peptides in the mouse pituitary. Acta histochemica 103:397-412
100. Itoi K, Mouri T, Takahashi K, Murakami O, Imai Y, Sasaki S, Yoshinaga K, Sasano N 1987 Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus. Neurosci Lett 73:231-236
101. Davis LG, Arentzen R, Reid JM, Manning RW, Wolfson B, Lawrence KL, Baldino F, Jr. 1986 Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat. Proc Natl Acad Sci U S A 83:1145-1149
102. Abou-Samra AB, Catt KJ, Aguilera G 1986 Biphasic inhibition of adrenocorticotropin release by corticosterone in cultured anterior pituitary cells. Endocrinology 119:972-977
103. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N 1987 Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43:113-173
104. Keller-Wood ME, Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24
105. Di S, Malcher-Lopes R, Halmos KC, Tasker JG 2003 Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850-4857
106. Suda T, Tomori N, Yajima F, Ushiyama T, Sumitomo T, Nakagami Y, Demura H, Shizume K 1987 A short negative feedback mechanism regulating corticotropin-releasing hormone release. J Clin Endocrinol Metab 64:909-913
107. Sawchenko PE, Arias C 1995 Evidence for short-loop feedback effects of ACTH on CRF and vasopressin expression in parvocellular neurosecretory neurons. J Neuroendocrinol 7:721-731
108. Horvath E, Kovacs K 1988 Fine structural cytology of the adenohypophysis in rat and man. J Electron Microsc Tech 8:401-432
109. Cohen LE, Radovick S 2002 Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23:431-442
110. Niall HD, Hogan ML, Sauer R, Rosenblum IY, Greenwood FC 1971 Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication. Proc Natl Acad Sci U S A 68:866-870
111. Owerbach D, Rutter WJ, Martial JA, Baxter JD, Shows TB 1980 Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science 209:289-292
112. McKusick V, Phillips JI, Bottani A, Antonarakis S, O'Neill M, Kniffin C, Hartz P, Gross M 2007 GROWTH HORMONE 1; GH1. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD, USA: Johns Hopkins University
113. Frankenne F, Rentier-Delrue F, Scippo ML, Martial J, Hennen G 1987 Expression of the growth hormone variant gene in human placenta. J Clin Endocrinol Metab 64:635-637
114. Liebhaber SA, Urbanek M, Ray J, Tuan RS, Cooke NE 1989 Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest 83:1985-1991
115. McKusick V, Phillips JI 2007 GROWTH HORMONE 2; GH2. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University
116. McKusick V, Phillips JI, Rasooly R 2007 CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University
117. McKusick V, Rasooly R 2007 CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University
118. Rasooly R 2007 CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1; CSHL1. In: McKusick V ed. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University
119. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH 1989 The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4:479-497
120. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M 1988 The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55:505-518
121. Lemaigre FP, Peers B, Lafontaine DA, Mathy-Hartert M, Rousseau GG, Belayew A, Martial JA 1989 Pituitary-specific factor binding to the human prolactin, growth hormone, and placental lactogen genes. DNA 8:149-159
122. Lemaigre FP, Courtois SJ, Durviaux SM, Egan CJ, LaFontaine DA, Rousseau GG 1989 Analysis of cis- and trans-acting elements in the hormone-sensitive human somatotropin gene promoter. J Steroid Biochem 34:79-83
123. Nachtigal MW, Nickel BE, Klassen ME, Zhang WG, Eberhardt NL, Cattini PA 1989 Human chorionic somatomammotropin and growth hormone gene expression in rat pituitary tumour cells is dependent on proximal promoter sequences. Nucleic Acids Res 17:4327-4337
124. Fox SR, Jong MT, Casanova J, Ye ZS, Stanley F, Samuels HH 1990 The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters. Mol Endocrinol 4:1069-1080
125. Tansey WP, Catanzaro DF 1991 Sp1 and thyroid hormone receptor differentially activate expression of human growth hormone and chorionic somatomammotropin genes. J Biol Chem 266:9805-9813
126. Nickel BE, Nachtigal MW, Bock ME, Cattini PA 1991 Differential binding of rat pituitary-specific nuclear factors to the 5'-flanking region of pituitary and placental members of the human growth hormone gene family. Mol Cell Biochem 106:181-187
127. Walker WH, Fitzpatrick SL, Saunders GF 1990 Human placental lactogen transcriptional enhancer. Tissue specificity and binding with specific proteins. J Biol Chem 265:12940-12948
128. Nachtigal MW, Nickel BE, Cattini PA 1993 Pituitary-specific repression of placental members of the human growth hormone gene family. A possible mechanism for locus regulation. J Biol Chem 268:8473-8479
129. Jones BK, Monks BR, Liebhaber SA, Cooke NE 1995 The human growth hormone gene is regulated by a multicomponent locus control region. Mol Cell Biol 15:7010-7021
130. Shewchuk BM, Liebhaber SA, Cooke NE 2002 Specification of unique Pit-1 activity in the hGH locus control region. Proc Natl Acad Sci U S A 99:11784-11789
131. Elefant F, Cooke NE, Liebhaber SA 2000 Targeted recruitment of histone acetyltransferase activity to a locus control region. J Biol Chem 275:13827-13834
132. Ho Y, Elefant F, Cooke N, Liebhaber S 2002 A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol Cell 9:291-302
133. Frohman LA, Burek L, Stachura MA 1972 Characterization of growth hormone of different molecular weights in rat, dog and human pituitaries. Endocrinology 91:262-269
134. Baumann G, Winter RJ, Shaw M 1987 Circulating molecular variants of growth hormone in childhood. Pediatr Res 22:21-22
135. Baumann G, Stolar MW, Amburn K 1985 Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. J Clin Endocrinol Metab 60:1216-1220
136. Herington AC, Ymer S, Stevenson J 1986 Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77:1817-1823
137. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
138. Baumann G, Shaw MA 1990 Plasma transport of the 20,000-dalton variant of human growth hormone (20K): evidence for a 20K-specific binding site. J Clin Endocrinol Metab 71:1339-1343
139. Ross RJ, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PR, Postel-Vinay MC, Finidori J 1997 A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 11:265-273
140. Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K 1982 Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70:965-977
141. Mayo K, Vale W, Rivier J, Rosenfeld M, Evans R 1983 Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature 306:86-88
142. Gubler U, Monahan J, Lomedico P, Bhatt R, Collier K, Hoffman B, Bohlen P, Esch F, Ling N, Zeytin F, Brazeau P, Poonian M, Gage L 1983 Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A 80:4311-4314
143. Mayo K 1992 Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol 6:1734-1744
144. Barinaga M, Yamonoto G, Rivier C, Vale W, Evans R, Rosenfeld M 1983 Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature 306:84-85
145. Fukata J, Diamond D, Martin J 1985 Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology 117:457-467
146. Campbell R, Scanes C 1992 Evolution of the growth hormone-releasing factor (GRF) family of peptides. Growth Regul 2:175-191
147. Shen L, Pictet R, Rutter W 1982 Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci U S A 79:4575-4579
148. Siler T, VandenBerg G, Yen S, Brazeau P, Vale W, Guillemin R 1973 Inhibition of growth hormone release in humans by somatostatin. J Clin Endocrinol Metab 37:632-634
149. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R 1973 Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
150. Tannenbaum GS, Epelbaum J, Bowers CY 2003 Interrelationship between the Novel Peptide Ghrelin and Somatostatin/Growth Hormone-Releasing Hormone in Regulation of Pulsatile Growth Hormone Secretion. Endocrinology 144:967-974
151. Broglio F, Koetsveld Pv P, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Gauna C, Hofland L, Deghenghi R, Arvat E, Van Der Lely AJ, Ghigo E 2002 Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 87:4829-4832
152. Norrelund H, Hansen TK, Orskov H, Hosoda H, Kojima M, Kangawa K, Weeke J, Moller N, Christiansen JS, Jorgensen JO 2002 Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) 57:539-546
153. Shimada M, Date Y, Mondal MS, Toshinai K, Shimbara T, Fukunaga K, Murakami N, Miyazato M, Kangawa K, Yoshimatsu H, Matsuo H, Nakazato M 2003 Somatostatin suppresses ghrelin secretion from the rat stomach. Biochem Biophys Res Commun 302:520-525
154. Vale W, Rivier C, Brazeau P, Guillemin R 1974 Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95:968-977
155. Siler TM, Yen SC, Vale W, Guillemin R 1974 Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J Clin Endocrinol Metab 38:742-745
156. Liddle R 2006 Physiology of somatostatin and its analogues. In: UpToDate version 143. Wellesley, MA, United States of America: UpToDate, Inc.
157. Patel Y, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson L, Srikant C 1996 Molecular biology of somatostatin receptor subtypes. Metabolism 45:31-38
158. Reisine T, Bell GI 1995 Molecular biology of somatostatin receptors. Endocr Rev 16:427-442
159. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
160. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
161. Hosoda H, Kojima M, Matsuo H, Kangawa K 2000 Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909-913
162. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K 1981 Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology 108:31-39
163. Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byrne DJ, MacColl GS, Keen JN, Bouloux PM, Mikhailidis DP, Bruckdorfer KR, Vanderpump MP, Srai KS 2003 Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase. J Biol Chem 278:8877-8880
164. De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C 2004 Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145:4997-5005
165. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB 2001 The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881-887
166. Caminos JE, Nogueiras R, Blanco M, Seoane LM, Bravo S, Alvarez CV, Garcia-Caballero T, Casanueva FF, Dieguez C 2003 Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland. Endocrinology 144:5089-5097
167. Wren A, Small C, Abbott C, Dhillo W, Seal L, Cohen M, Batterham R, Taheri S, Stanley S, Ghatei M, Bloom S 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
168. Wren A, Seal L, Cohen M, Brynes A, Frost G, Murphy K, Dhillo W, Ghatei M, Bloom S 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
169. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal M, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S 2002 Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51:124-129
170. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
171. Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981
172. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW 2004 Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci U S A 101:8227-8232
173. Sun Y, Wang P, Zheng H, Smith RG 2004 Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 101:4679-4684
174. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. The Journal of cell biology 159:1029-1037
175. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M, Muccioli G 2004 Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173-184
176. Muccioli G, Pons N, Ghe C, Catapano F, Granata R, Ghigo E 2004 Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498:27-35
177. Tsubota Y, Owada-Makabe K, Yukawa K, Maeda M 2005 Hypotensive effect of des-acyl ghrelin at nucleus tractus solitarii of rat. Neuroreport 16:163-166
178. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M 2005 Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18-24
179. Neary NM, Druce MR, Small CJ, Bloom SR 2006 Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 55:135
180. Chen CY, Inui A, Asakawa A, Fujino K, Kato I, Chen CC, Ueno N, Fujimiya M 2005 Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129:8-25
181. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947
182. Seoane LM, Tovar S, Baldelli R, Arvat E, Ghigo E, Casanueva FF, Dieguez C 2000 Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol 143:R7-9
183. Bowers CY, Sartor AO, Reynolds GA, Badger TM 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128:2027-2035
184. Casanueva FF, Burguera B, Muruais C, Dieguez C 1990 Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 70:234-237
185. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva FF 1990 Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology 51:51-58
186. Strickland AL, Underwood LE, Voina SJ, French FS, Van Wyk JJ 1972 Growth retardation in Cushing's syndrome. Am J Dis Child 123:207-213
187. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
188. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543
189. Schwartz MW, Woods SC, Porte D, Jr., Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
190. Jin L, Burguera BG, Couce ME, Scheithauer BW, Lamsan J, Eberhardt NL, Kulig E, Lloyd RV 1999 Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab 84:2903-2911
191. Korbonits M, Chitnis MM, Gueorguiev M, Norman D, Rosenfelder N, Suliman M, Jones TH, Noonan K, Fabbri A, Besser GM, Burrin JM, Grossman AB 2001 The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) 54:781-789
192. Kristiansen MT, Clausen LR, Nielsen S, Blaabjerg O, Ledet T, Rasmussen LM, Jorgensen JO 2004 Expression of leptin receptor isoforms and effects of leptin on the proliferation and hormonal secretion in human pituitary adenomas. Horm Res 62:129-136
193. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C 1997 Regulation of in vivo growth hormone secretion by leptin. Endocrinology 138:2203-2206
194. Massara F, Camanni F 1972 Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion. J Endocrinol 54:195-206
195. Chihara K, Minamitani N, Kaji H, Kodama H, Kita T, Fujita T 1984 Noradrenergic modulation of human pancreatic growth hormone-releasing factor (hpGHRF1-44)-induced growth hormone release in conscious male rabbits: involvement of endogenous somatostatin. Endocrinology 114:1402-1406
196. Milner RD, Burns EC 1982 Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee. Arch Dis Child 57:944-947
197. Grossman A, Weerasuriya K, Al-Damluji S, Turner P, Besser GM 1987 Alpha 2-adrenoceptor agonists stimulate growth hormone secretion but have no acute effects on plasma cortisol under basal conditions. Horm Res 25:65-71
198. Masala A, Delitala G, Alagna S, Devilla L 1977 Effect of pimozide on levodopa-induced growth hormone release in man. Clin Endocrinol (Oxf) 7:253-256
199. Cammani F, Massara F 1972 Phentolamine inhibition of human growth hormone secretion induced by L-DOPA. Horm Metab Res 4:128
200. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
201. Friend K, Iranmanesh A, Login IS, Veldhuis JD 1997 Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur J Endocrinol 137:377-386
202. Taylor BJ, Smith PJ, Brook CG 1985 Inhibition of physiological growth hormone secretion by atropine. Clin Endocrinol (Oxf) 22:497-501
203. Massara F, Ghigo E, Demislis K, Tangolo D, Mazza E, Locatelli V, Muller EE, Molinatti GM, Camanni F 1986 Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. Neuroendocrinology 43:670-675
204. Wehrenberg WB, Wiviott SD, Voltz DM, Giustina A 1992 Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 130:1445-1450
205. Grossman A 1983 Brain opiates and neuroendocrine function. Clin Endocrinol Metab 12:725-746
206. Moretti C, Fabbri A, Gnessi L, Cappa M, Calzolari A, Fraioli F, Grossman A, Besser GM 1983 Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin Endocrinol (Oxf) 18:135-138
207. Miki N, Ono M, Shizume K 1984 Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF). Endocrinology 114:1950-1952
208. Delitala G, Tomasi PA, Palermo M, Ross RJ, Grossman A, Besser GM 1989 Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. J Clin Endocrinol Metab 69:356-358
209. Wenger T, Toth BE, Martin BR 1995 Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci 56:2057-2063
210. Rettori V, Wenger T, Snyder G, Dalterio S, McCann SM 1988 Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat. Neuroendocrinology 47:498-503
211. Rettori V, Aguila MC, Gimeno MF, Franchi AM, McCann SM 1990 In vitro effect of delta 9-tetrahydrocannabinol to stimulate somatostatin release and block that of luteinizing hormone-releasing hormone by suppression of the release of prostaglandin E2. Proc Natl Acad Sci U S A 87:10063-10066
212. Giustina A, Licini M, Schettino M, Doga M, Pizzocolo G, Negro-Vilar A 1994 Physiological role of galanin in the regulation of anterior pituitary function in humans. Am J Physiol 266:E57-61
213. Cantalamessa L, Catania A, Reschini E, Peracchi M 1978 Inhibitory effect of calcitonin on growth hormone and insulin secretion in man. Metabolism 27:987-992
214. Petralito A, Lunetta M, Liuzzo A, Mangiafico RA, Fiore CE 1979 Effects of salmon calcitonin on insulin-induced growth hormone release in man. Horm Metab Res 11:641-643
215. Harfstrand A, Eneroth P, Agnati L, Fuxe K 1987 Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul Pept 17:167-179
216. Rettori V, Milenkovic L, Aguila MC, McCann SM 1990 Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 126:2296-2301
217. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML 1993 Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 132:224-234
218. Adams EF, Venetikou MS, Woods CA, Lacoumenta S, Burrin JM 1987 Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours. Acta Endocrinol (Copenh) 115:149-154
219. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB 1999 The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 11:521-528
220. Watanobe H, Tamura T 1996 Stimulation by neuropeptide Y of growth hormone secretion in prolactinoma in vivo. Neuropeptides 30:429-432
221. Antonijevic IA, Murck H, Bohlhalter S, Frieboes RM, Holsboer F, Steiger A 2000 Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39:1474-1481
222. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574
223. Goth MI, Lyons CE, Canny BJ, Thorner MO 1992 Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130:939-944
224. Jarry H, Leonhardt S, Schmidt WE, Creutzfeldt W, Wuttke W 1992 Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats. Life Sci 51:823-830
225. Propato-Mussafiri R, Kanse SM, Ghatei MA, Bloom SR 1992 Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3. J Endocrinol 132:107-113
226. Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, Coiro V 1996 Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal Hormone secretion in normal men. Neuroendocrinology 64:242-246
227. Peterfreund RA, Vale WW 1984 Somatostatin analogs inhibit somatostatin secretion from cultured hypothalamus cells. Neuroendocrinology 39:397-402
228. Aguila MC, McCann SM 1985 The influence of hGRF, CRF, TRH and LHRH on SRIF release from median eminence fragments. Brain Res 348:180-182
229. Sheppard MC, Kronheim S, Pimstone BL 1978 Stimulation by growth hormone of somatostatin release from the rat hypothalamus in vitro. Clin Endocrinol (Oxf) 9:583-586
230. Ross RJ, Tsagarakis S, Grossman A, Nhagafoong L, Touzel RJ, Rees LH, Besser GM 1987 GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clin Endocrinol (Oxf) 27:727-733
231. Aguila MC, McCann SM 1993 Growth hormone increases somatostatin release and messenger ribonucleic acid levels in the rat hypothalamus. Brain Res 623:89-94
232. Qi X, Reed J, Englander EW, Chandrashekar V, Bartke A, Greeley GH, Jr. 2003 Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. Exp Biol Med (Maywood) 228:1028-1032
233. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279-1281
234. Yamashita S, Melmed S 1986 Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 118:176-182
235. Iranmanesh A, Grisso B, Veldhuis JD 1994 Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 78:526-535
236. Toogood AA, Nass RM, Pezzoli SS, O'Neill PA, Thorner MO, Shalet SM 1997 Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. J Clin Endocrinol Metab 82:2215-2221
237. Tannenbaum GS, Painson JC, Lengyel AM, Brazeau P 1989 Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Endocrinology 124:1380-1388
238. Vance ML, Kaiser DL, Martha PM, Jr., Furlanetto R, Rivier J, Vale W, Thorner MO 1989 Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. J Clin Endocrinol Metab 68:22-28
239. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM 2001 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464
240. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F 1996 An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81:2460-2467
241. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 78:1312-1319
242. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94:7239-7244
243. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G 1992 A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 74:1441-1450
244. Holl RW, Hartman ML, Veldhuis JD, Taylor WM, Thorner MO 1991 Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab 72:854-861
245. Van Cauter E, Leproult R, Plat L 2000 Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. Jama 284:861-868
246. Van Cauter E, Latta F, Nedeltcheva A, Spiegel K, Leproult R, Vandenbril C, Weiss R, Mockel J, Legros JJ, Copinschi G 2004 Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 14 Suppl A:S10-17
247. Golstein J, Van Cauter E, Desir D, Noel P, Spire JP, Refetoff S, Copinschi G 1983 Effects of "jet lag" on hormonal patterns. IV. Time shifts increase growth hormone release. J Clin Endocrinol Metab 56:433-440
248. Jaffe CA, Friberg RD, Barkan AL 1993 Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest 92:695-701
249. Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL 1995 Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study. J Clin Endocrinol Metab 80:3321-3326
250. Yildiz BO, Suchard MA, Wong M-L, McCann SM, Licinio J 2004 Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. PNAS 101:10434-10439
251. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F 1992 Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56:566-573
252. Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A 2003 Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 284:E407-415
253. Sutton J, Lazarus L 1976 Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J Appl Physiol 41:523-527
254. Lassarre C, Girard F, Durand J, Raynaud J 1974 Kinetics of human growth hormone during submaximal exercise. J Appl Physiol 37:826-830
255. Raynaud J, Capderou A, Martineaud JP, Bordachar J, Durand J 1983 Intersubject variability in growth hormone time course during different types of work. J Appl Physiol 55:1682-1687
256. Felsing NE, Brasel JA, Cooper DM 1992 Effect of low and high intensity exercise on circulating growth hormone in men. J Clin Endocrinol Metab 75:157-162
257. Vanhelder WP, Goode RC, Radomski MW 1984 Effect of anaerobic and aerobic exercise of equal duration and work expenditure on plasma growth hormone levels. Eur J Appl Physiol Occup Physiol 52:255-257
258. Schmidt A, Maier C, Schaller G, Nowotny P, Bayerle-Eder M, Buranyi B, Luger A, Wolzt M 2004 Acute exercise has no effect on ghrelin plasma concentrations. Horm Metab Res 36:174-177
259. Roth J, Glick SM, Yalow RS, Berson SA 1963 Hypoglycemia: a potent stimulus to secretion of growth hormone. Science 140:987-988
260. Greenwood FC, Landon J, Stamp TC 1966 The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest 45:429-436
261. Hindmarsh PC, Smith PJ, Taylor BJ, Pringle PJ, Brook CG 1985 Comparison between a physiological and a pharmacological stimulus of growth hormone secretion: response to stage IV sleep and insulin-induced hypoglycaemia. Lancet 2:1033-1035
262. Tatar P, Vigas M 1984 Role of alpha 1- and alpha 2-adrenergic receptors in the growth hormone and prolactin response to insulin-induced hypoglycemia in man. Neuroendocrinology 39:275-280
263. Jaffe CA, DeMott-Friberg R, Barkan AL 1996 Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest 97:934-940
264. Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E 2004 Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf) 60:699-704
265. Carey LC, Cloutier CT, Lowery BD 1971 Growth hormone and adrenal cortical response to shock and trauma in the human. Ann Surg 174:451-460
266. Vigas M, Malatinsky J, Nemeth S, Jurcovicova J 1977 Alpha-adrenergic control of growth hormone release during surgical stress in man. Metabolism 26:399-402
267. Roth A, Cligg SM, Yalow RS, Berson SA 1963 Secretion of growth hormone: physiological and experimental modification. Metabolism 12:557-559
268. Penalva A, Burguera B, Casabiell X, Tresguerres JA, Dieguez C, Casanueva FF 1989 Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin? Neuroendocrinology 49:551-554
269. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S 2002 Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
270. Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, Maccario M, Casanueva FF, Dieguez C, Deghenghi R, Ghigo E, Arvat E 2002 Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57:265-271
271. Hayford JT, Danney MM, Hendrix JA, Thompson RG 1980 Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 29:391-398
272. Asplin CM, Faria AC, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS 1989 Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:239-245
273. Salgado LR, Semer M, Nery M, Knoepfelmacher M, Lerario AC, Povoa G, Jana S, Villares SM, Wajchenberg BL, Liberman B, Nicolau W 1996 Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus. J Endocrinol Invest 19:433-440
274. Soliman AT, Hassan AE, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD 1986 Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20:1122-1130
275. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO 1988 Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968-975
276. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
277. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS 1997 Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol 272:E1108-1116
278. Ghigo E, Mazza E, Corrias A, Imperiale E, Goffi S, Arvat E, Bellone J, De Sanctis C, Muller EE, Camanni F 1989 Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. Metabolism 38:631-633
279. Loche S, Pintor C, Cappa M, Ghigo E, Puggioni R, Locatelli V, Muller EE 1989 Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinol (Copenh) 120:624-628
280. Cordido F, Casanueva FF, Dieguez C 1989 Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab 68:290-293
281. Cordido F, Penalva A, Peino R, Casanueva FF, Dieguez C 1995 Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects. Metabolism 44:745-748
282. Ozata M, Dieguez C, Casanueva FF 2003 The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. J Clin Endocrinol Metab 88:312-316
283. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709
284. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO 2002 Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56:203-206
285. Leidy HJ, Gardner JK, Frye BR, Snook ML, Schuchert MK, Richard EL, Williams NI 2004 Circulating Ghrelin Is Sensitive to Changes in Body Weight during a Diet and Exercise Program in Normal-Weight Young Women. J Clin Endocrinol Metab 89:2659-2664
286. Lindeman JH, Pijl H, Van Dielen FM, Lentjes EG, Van Leuven C, Kooistra T 2002 Ghrelin and the hyposomatotropism of obesity. Obes Res 10:1161-1166
287. Sukkar MY, Hunter WM, Passmore R 1967 Changes in plasma levels of insulin and growth-hormone levels after a protein meal. Lancet 2:1020-1022
288. Parker ML, Hammond JM, Daughaday WH 1967 The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J Clin Endocrinol Metab 27:1129-1136
289. Alba-Roth J, Muller OA, Schopohl J, von Werder K 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189